Literature DB >> 28427555

Impact of cavity and infiltration on pulmonary function and health-related quality of life in pulmonary Mycobacterium avium complex disease: A 3-dimensional computed tomographic analysis.

Takanori Asakura1, Yoshitake Yamada2, Ho Namkoong3, Shoji Suzuki3, Yuki Niijima4, Hirofumi Kamata3, Yohei Funatsu3, Kazuma Yagi3, Satoshi Okamori3, Hiroaki Sugiura4, Makoto Ishii3, Masahiro Jinzaki4, Tomoko Betsuyaku3, Naoki Hasegawa5.   

Abstract

BACKGROUND AND OBJECTIVES: Pulmonary Mycobacterium avium complex (pMAC) disease manifests as various types of lesions, such as infiltrates, nodules, cavities, and bronchiectasis. However, the important determinants for clinical parameters in lung involvement are poorly understood. The objective of this study was to obtain quantitative parameters by 3-dimensional CT, and investigate the relationship between these parameters and the pulmonary function tests (PFTs) and health-related quality of life.
MATERIAL AND METHODS: Quantitative analysis using CT was performed in 67 pMAC patients. The relationship between new quantitative parameters for evaluating lung involvement using 3-dimensional CT and PFTs or St George's Respiratory Questionnaire (SGRQ) was evaluated.
RESULTS: The ratio of infiltration to total lung volume showed significant correlation with the PFT results, especially the percent-predicted forced vital capacity (%FVC; ρ = -0.52), residual volume (ρ = -0.51), and total lung capacity (ρ = -0.59). The cavity volume was strongly correlated with the %FVC (ρ = -0.78) in the cavity group, while the ratio of infiltration to total lung volume was strongly correlated with the %FVC (ρ = -0.53) in the non-cavity group. The ratio of infiltration to total lung volume was significantly correlated with all SGRQ parameters (ρ = 0.41-0.52) in the non-cavity group.
CONCLUSIONS: Infiltration was an important parameter for the PFTs and SGRQ in pMAC patients according to the 3-dimensional CT analysis. Moreover, cavity volume was an important parameter of the PFTs in the cavity group. Therefore, infiltration and cavity volume are key features for the management of pMAC disease.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3-Dimensional computed tomographic analysis; Computed tomography; Health-related quality of life; Mycobacterium avium complex; Nontuberculous mycobacteria; Pulmonary function

Mesh:

Year:  2017        PMID: 28427555     DOI: 10.1016/j.rmed.2017.03.010

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Osteoporosis in nontuberculous mycobacterial pulmonary disease: a cross-sectional study.

Authors:  Hiromu Tanaka; Takanori Asakura; Shoji Suzuki; Satoshi Okamori; Tatsuya Kusumoto; Takunori Ogawa; Shunsuke Uno; Atsuho Morita; Ho Lee; Ho Namkoong; Hirofumi Kamata; Yasunori Sato; Yoshifumi Uwamino; Tomoyasu Nishimura; Makoto Ishii; Koichi Fukunaga; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2022-05-21       Impact factor: 3.320

2.  Physical Function and Health-Related Quality of Life after Surgery for Nontuberculous Mycobacterial Pulmonary Disease: A Prospective Cohort Study.

Authors:  Yuki Kuroyama; Mitsuru Tabusadani; Shunya Omatsu; Miyako Hiramatsu; Yuji Shiraishi; Hiroshi Kimura; Hideaki Senjyu
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-08-26       Impact factor: 1.889

3.  Impact of chronic Pseudomonas aeruginosa infection on health-related quality of life in Mycobacterium avium complex lung disease.

Authors:  Hirofumi Kamata; Takanori Asakura; Shoji Suzuki; Ho Namkoong; Kazuma Yagi; Yohei Funatsu; Satoshi Okamori; Shunsuke Uno; Yoshifumi Uwamino; Hiroshi Fujiwara; Tomoyasu Nishimura; Makoto Ishii; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2017-12-13       Impact factor: 3.317

4.  Sitafloxacin-Containing Regimen for the Treatment of Refractory Mycobacterium avium Complex Lung Disease.

Authors:  Takanori Asakura; Shoji Suzuki; Hanako Fukano; Satoshi Okamori; Tatsuya Kusumoto; Yoshifumi Uwamino; Takunori Ogawa; Matsuo So; Shunsuke Uno; Ho Namkoong; Mitsunori Yoshida; Hirofumi Kamata; Makoto Ishii; Tomoyasu Nishimura; Yoshihiko Hoshino; Naoki Hasegawa
Journal:  Open Forum Infect Dis       Date:  2019-03-07       Impact factor: 3.835

5.  Pulmonary Densitovolumetry Using Computed Tomography in Patients with Nontuberculous Mycobacteria: Correlation with Pulmonary Function Tests.

Authors:  Patricia Gomes Cytrangulo De Marca; Telma Goldenberg; Fernanda Carvalho Queiroz Mello; Alysson Roncally Silva Carvalho; Alan Ranieri Medeiros Guimarães; Roberto Mogami; Agnaldo José Lopes
Journal:  Pulm Med       Date:  2019-02-03

6.  Serum oxidative stress in patients with pulmonary Mycobacterium avium complex disease.

Authors:  Hiroki Wakabayashi; Yasuo Matsuzawa; Sho Hayakawa; Tamako Irie; Hagino Rikitake; Ichiro Tatsuno
Journal:  Heliyon       Date:  2019-11-14

7.  Correlation between serum carbohydrate antigen 19-9 levels and computed tomography severity score in patients with nontuberculous mycobacterial pulmonary disease.

Authors:  Kangjoon Kim; Seung Hyun Yong; Su Hwan Lee; Sang Hoon Lee; Ah Young Leem; Song Yee Kim; Kyungsoo Chung; Eun Young Kim; Ji Ye Jung; Moo Suk Park; Young Sam Kim; Hye-Jeong Lee; Young Ae Kang
Journal:  Sci Rep       Date:  2021-02-02       Impact factor: 4.379

8.  Association between six-minute walk test parameters and the health-related quality of life in patients with pulmonary Mycobacterium avium complex disease.

Authors:  Kazuma Yagi; Takanori Asakura; Ho Namkoong; Shoji Suzuki; Takahiro Asami; Satoshi Okamori; Tatsuya Kusumoto; Yohei Funatsu; Hirofumi Kamata; Tomoyasu Nishimura; Makoto Ishii; Tomoko Betsuyaku; Naoki Hasegawa
Journal:  BMC Pulm Med       Date:  2018-07-13       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.